Published in Schizophr Bull on January 11, 2006
The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull (2009) 2.38
The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology (2012) 1.32
The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders. Schizophr Bull (2015) 0.98
Cognition and brain function in schizotypy: a selective review. Schizophr Bull (2015) 0.92
Perceived threat mediates the relationship between psychosis proneness and aggressive behavior. Psychiatry Res (2010) 0.77
Neurological soft signs in early stage of schizophrenia associated with obsessive-compulsive disorder. J Med Life (2015) 0.75
Potential microbial origins of schizophrenia and their treatments. Drugs Today (Barc) (2009) 0.75
A Study of Soft Neurological Signs and Its Correlates in Drug-Naive Patients with First Episode Psychosis. Indian J Psychol Med (2016) 0.75
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use. Ann Gen Psychiatry (2017) 0.75
Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol (1994) 2.53
The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res (1989) 2.00
Neurological abnormalities in familial and sporadic schizophrenia. Brain (1998) 1.68
Neurological soft signs in schizophrenia. Br J Psychiatry (1990) 1.67
Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2005) 1.58
Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br J Psychiatry (2002) 1.56
Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry (1988) 1.36
Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology (2006) 1.23
Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl (2002) 1.15
Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry (1995) 1.13
Neurologic soft signs and low birthweight: their association and neuropsychiatric implications. Biol Psychiatry (2000) 1.09
Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry (2001) 1.05
Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res (2000) 1.02
Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophr Res (2004) 1.02
Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci (1999) 0.98
Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry (1999) 0.96
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res (1999) 0.95
Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr Res (2002) 0.94
Visual-motor disorders in infants at risk for schizophrenia. Arch Gen Psychiatry (1973) 0.90
A risk factor screening and assessment protocol for schizophrenia and related psychosis. Aust N Z J Psychiatry (2000) 0.90
Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res (1996) 0.90
Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma? Acta Psychiatr Scand (2000) 0.90
Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. Am J Psychiatry (2000) 0.88
Neurological soft signs in obsessive compulsive disorder: standardised assessment and comparison with schizophrenia. Behav Neurol (1998) 0.88
Neurologic signs of cerebellar and cortical sensory dysfunction in schizophrenics and their relatives. Schizophr Res (1999) 0.87
Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand (2003) 0.86
Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophr Res (1998) 0.86
Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. J Affect Disord (1983) 0.85
Neurologic abnormalities in schizophrenic patients and their families. II. Neurologic and psychiatric findings in relatives. Arch Gen Psychiatry (1986) 0.85
The assessment of schizotypal features over two points in time. Schizophr Res (1991) 0.84
Neurological findings in high-risk children: childhood assessment and 5-year followup. Schizophr Bull (1985) 0.84
Value of equivocal signs in neurologic diagnosis. Neurology (1960) 0.83
Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr Scand (1994) 0.83
Neurological soft signs are associated with APOE genotype, age and cognitive performance. J Alzheimers Dis (2005) 0.83
Integration of soft signs in academically normal and academically at-risk children. Pediatrics (1990) 0.82
Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry (1986) 0.82
Intellectual psycho-educational and functional status of low birth weight survivors beyond 5 years of age. Indian J Pediatr (2000) 0.81
Neurological soft signs in Nigerian schizophrenics: a controlled study. Acta Psychiatr Scand (1988) 0.81
Neurological "hard" signs and family history of psychosis in schizophrenia. Biol Psychiatry (1991) 0.78
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Neuronal correlates of theory of mind and empathy: a functional magnetic resonance imaging study in a nonverbal task. Neuroimage (2005) 3.38
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol (2012) 2.75
Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. Br J Psychiatry (2004) 2.54
Beyond Munchausen syndrome by proxy: identification and treatment of child abuse in a medical setting. Pediatrics (2007) 2.21
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial. Br J Psychiatry (2003) 1.78
A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res (2013) 1.58
First report of Mycobacterium bovis DNA in human remains from the Iron Age. Microbiology (2007) 1.51
Superior demonstration of splenosis by heat-denatured Tc-99m red blood cell scintigraphy compared with Tc-99m sulfur colloid scintigraphy. Clin Nucl Med (2006) 1.24
The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res (2006) 1.20
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol (2012) 1.19
Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res (2005) 1.15
Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr Res (2003) 1.14
B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol (2012) 1.13
Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry (2013) 1.11
Understanding the behavioral and emotional consequences of child abuse. Pediatrics (2008) 1.11
Identification of mosquito repellent odours from Ocimum forskolei. Parasit Vectors (2011) 1.11
CATIE and CUtLASS: can we handle the truth? Br J Psychiatry (2008) 1.09
Evidence of sexual assault in prepubertal girls. Med Sci Law (2013) 1.05
Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study. Crim Behav Ment Health (2004) 1.03
Clinical report—the pediatrician’s role in child maltreatment prevention. Pediatrics (2010) 1.02
Fine motor skill performance in left- and right-handers: Evidence of an advantage for left-handers. Laterality (2003) 1.00
The evolution of symptoms in the early course of non-affective psychosis. Schizophr Res (2003) 0.97
Cognitive and neural processes in non-clinical auditory hallucinations. Br J Psychiatry Suppl (2007) 0.97
Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes. Hum Genet (2009) 0.97
Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009. Emerg Infect Dis (2010) 0.91
Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions. Ann Thorac Surg (2005) 0.91
Psychological interventions in early psychosis. Schizophr Bull (2005) 0.90
Essential elements of an early intervention service for psychosis: the opinions of expert clinicians. BMC Psychiatry (2004) 0.90
Prospects for a cognitive-developmental account of psychotic experiences. Br J Clin Psychol (2007) 0.90
Efficient linking of birth certificate and newborn screening databases for laboratory investigation of congenital cytomegalovirus infection and preterm birth: Florida, 2008. Matern Child Health J (2012) 0.89
Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine. Vaccine (2009) 0.86
Evaluation of state-provided postexposure prophylaxis against rabies in Florida. South Med J (2002) 0.86
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine. Value Health (2007) 0.85
Dual diagnosis clients' treatment satisfaction - a systematic review. BMC Psychiatry (2011) 0.84
Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addict Behav (2009) 0.84
Auditory false perceptions are mediated by psychosis risk factors. Cogn Neuropsychiatry (2010) 0.84
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology (2005) 0.84
Treatment approaches for dual diagnosis clients in England. Drug Alcohol Rev (2008) 0.83
Ovine panel reactive antibody assay of HLA responsivity to allograft bioengineered vascular scaffolds. J Thorac Cardiovasc Surg (2005) 0.81
Assessing illicit substance use in schizophrenia: the relationship between self report and detection by hair analysis. Schizophr Res (2009) 0.80
The negative and positive self: a longitudinal study examining self-esteem, paranoia and negative symptoms in individuals with first-episode psychosis. Early Interv Psychiatry (2011) 0.80
Mood variability predicts the course of suicidal ideation in individuals with first and second episode psychosis. Psychiatry Res (2012) 0.79
Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatry (2006) 0.79
A combined yeast/bacteria two-hybrid system: development and evaluation. Mol Cell Proteomics (2005) 0.78
The cerebellar deficit hypothesis and dyslexic tendencies in a non-clinical sample. Dyslexia (2005) 0.78
In vitro analysis of the TAT protein transduction domain as a drug delivery vehicle in protozoan parasites. Exp Parasitol (2007) 0.77
Distress and metacognition in psychosis prone individuals: comparing high schizotypy to the at-risk mental state. J Nerv Ment Dis (2010) 0.77
Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial. Trials (2013) 0.75
The European First-Episode Schizophrenia Network. Br J Psychiatry Suppl (2002) 0.75
Giant parallel tubular arrays in T lymphocytes. Blood (2013) 0.75
Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study. Int J Psychiatry Clin Pract (2005) 0.75
Pyrrhocoricin as a potential drug delivery vehicle for Cryptosporidium parvum. Exp Parasitol (2008) 0.75
Two cases of warfarin-induced tracheobronchial calcification after Fontan surgery. Pediatr Cardiol (2014) 0.75